A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved

Gene

Volumn 297, Issue 1-2, 2002, Pages 141-149

  Alpen, Birgit ^a   Güre, Ali O ^b   Scanlan, Matthew J ^b   Old, Lloyd J ^b   Chen, Yao Tseng ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

Cancer vaccine; Cancer testis antigen; Immunotherapy

Indexed keywords

GENE PRODUCT; MESSENGER RNA; PROTEIN; PROTEIN ESO1; PROTEIN ESO2; PROTEIN NY ESO 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CHROMOSOME 9; CONTROLLED STUDY; DATA BASE; EXON; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE STRUCTURE; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; INTRON; MALE; MOLECULAR CLONING; MOUSE; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOGENE; RAT; RODENT; SEQUENCE HOMOLOGY; TESTIS; X CHROMOSOME;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; BASE SEQUENCE; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; GENE EXPRESSION; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; PROTEINS; PSEUDOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TESTIS;

RODENTIA;

EID: 0037019819     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(02)00879-X     Document Type: Article

References (25)

1. Aarnoudse C.A., van den Doel P.B., Heemskerk B., Schrier P.I. Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1. Int. J. Cancer. 82:1999;442-448.
2. Aradhya S., Bardaro T., Galgoczy P., Yamagata T., Esposito T., Patlan H., Ciccodicola A., Munnich A., Kenwrick S., Platzer M., D'Urso M., Nelson D.L. Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum. Mol. Genet. 10:2001;2557-2567.
3. Boel P., Wildmann C., Sensi M.L., Brasseur R., Renauld J.C., Coulie P., Boon T., van der Bruggen P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2:1995;167-175.
4. Chen Y.T., Scanlan M.J., Sahin U., Tureci O., Gure A.O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., Old L.J. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA. 94:1997;1914-1918.
5. Chen Y.T., Boyer A.D., Viars C.S., Tsang S., Old L.J., Arden K.C. Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28. Cytogenet. Cell Genet. 79:1997;237-240.
6. Chomez P., De Backer O., Bertrand M., De Plaen E., Boon T., Lucas S. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 61:2001;5544-5551.
7. De Backer O., Arden K.C., Boretti M., Vantomme V., De Smet C., Czekay S., Viars C.S., De Plaen E., Brasseur F., Chomez P., Van den Eynde B., Boon T., van der Bruggen P. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res. 59:1999;3157-3165.
8. De Smet C., Lurquin C., Lethe B., Martelange V., Boon T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19:1999;7327-7335.
9. Faranda S., Frattini A., Zucchi I., Patrosso C., Milanesi L., Montagna C., Vezzoni P. Characterization and fine localization of two new genes in Xq28 using the genomic sequence/EST database screening approach. Genomics. 34:1996;323-327.
10. Gnjatic S., Nagata Y., Jager E., Stockert E., Shankara S., Roberts B.L., Mazzara G.P., Lee S.Y., Dunbar P.R., Dupont B., Cerundolo V., Ritter G., Chen Y.T., Knuth A., Old L.J. Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc. Natl. Acad. Sci. USA. 97:2000;10917-10922.
11. Gure A.O., Tureci O., Sahin U., Tsang S., Scanlan M.J., Jager E., Knuth A., Pfreundschuh M., Old L.J., Chen Y.T. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int. J. Cancer. 72:1997;965-971.
12. Jager E., Chen Y.T., Drijfhout J.W., Karbach J., Ringhoffer M., Jager D., Arand M., Wada H., Noguchi Y., Stockert E., Old L.J., Knuth A. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187:1998;265-270.
13. Jager E., Jager D., Karbach J., Chen Y.T., Ritter G., Nagata Y., Gnjatic S., Stockert E., Arand M., Old L.J., Knuth A. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4z.ast;0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J. Exp. Med. 191:2001;625-630.
14. Lethe B., Lucas S., Michaux L., De Smet C., Godelaine D., Serrano A., De Plaen E., Boon T. LAGE-1, a new gene with tumor specificity. Int. J. Cancer. 76:1998;903-908.
15. Lucas S., Brasseur F., Boon T. A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells. Cancer Res. 59:1999;4100-4103.
16. Meuwissen R.L., Meerts I., Hoovers J.M., Leschot N.J., Heyting C. Human synaptonemal complex protein 1 (SCP1): isolation and characterization of the cDNA and chromosomal localization of the gene. Genomics. 39:1997;377-384.
17. Ono T., Kurashige T., Harada N., Noguchi Y., Saika T., Niikawa N., Aoe M., Nakamura S., Higashi T., Hiraki A., Wada H., Kumon H., Old L.J., Nakayama E. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc. Natl. Acad. Sci. USA. 98:2001;3282-3287.
18. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science. 293:2001;1089-1093.
19. Rimoldi D., Rubio-Godoy V., Dutoit V., Lienard D., Salvi S., Guillaume P., Speiser D., Stockert E., Spagnoli G., Servis C., Cerottini J.C., Lejeune F., Romero P., Valmori D. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and non-primary open reading frame-derived CTL epitopes in melanoma. J. Immunol. 165:2000;7253-7261.
20. Stockert E., Jager E., Chen Y.T., Scanlan M.J., Gout I., Karbach J., Arand M., Knuth A., Old L.J. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med. 187:1998;1349-1354.
21. Tureci O., Sahin U., Zwick C., Koslowski M., Seitz G., Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc. Natl. Acad. Sci. USA. 95:1998;5211-5216.
22. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., Van den Eynde B., Knuth A., Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1991;1643-1647.
23. Wang R.F., Johnston S.L., Zeng G., Topalian S.L., Schwartzentruber D.J., Rosenberg S.A. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. J. Immunol. 161:1998;3598-3606.
24. Zarour H.M., Storkus W.J., Brusic V., Williams E., Kirkwood J.M. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. Cancer Res. 60:2000;4946-4952.
25. Zeng G., Wang X., Robbins P.F., Rosenberg S.A., Wang R.F. CD4(+) T cell recognition of MHC class II-restricted epitopes from NY- ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production. Proc. Natl. Acad. Sci. USA. 98:2001;3964-3999.